Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Efficacy of chondroprotectives in canine joint diseases
Chondroprotectives like chondroitinsulfate or mussel extract are often used by owners of dogs with chronic joint diseases. The reported results are extremely different. A group from the University of Munich performed a placebo-controlled double-blind study with some surprising results...

In the study, dog ownersÂ’ perceptions of the effects of either chondroitin sulfate (CS) or New Zealand green-lipped mussel extract (Perna canaliculus, ME) to a placebo (PL) in dogs with a chronic degenerative joint disease was compared in a double-blind field study.

The evaluation of the questionnaires of the attending veterinarians revealed very good correspondence between the judgment of owners and experts. Both groups reported a slight improvement of the symptoms regarding the means of all three treatment groups including the placebo group. Some symptoms even improved more in the latter than in the groups receiving the test substances.

In conclusion, the dog owners as well as the attending veterinarians, who generally agreed with the owners, perceived only a slight improvement in all three groups including the placebo group.
However, in all three groups some dog owners observed enormous improvements. Possible reasons for these observation may have been a coincidence of the onset of treatment and a spontaneous transient improvement of the lameness or by an optimistic perception of the effects.

The effects of the placebo as well as the good agreement between the scoring of the owners and the veterinarians strongly suggest that case reports and studies that are not carried out double blind may be of limited value in assessing the effectiveness of chondroprotectives.

Source: B Dobenecker, Y Beetz, E Kienzle (2002): A placebo-controlled double-blind study on the effect of nutraceuticals (Chondroitin sulfate and mussel extract) in dogs with joint diseases as perceived by their owners. In: Journal of Nutrition, 2002, Vol 132, Iss 6, Suppl. 2, pp 1690-1691






Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Patient-specific facemask to facilitate brain biopsymembers
The objective of this pilot study was to describe the application and first preliminary data of a novel MRI and CT compatible patient-specific facemask for stereotactic brain biopsy of intracranial lesions in dogs. Five client-owned dogs presenting for neurological deficits consistent with forebrain disease were included in the study. All dogs had MRI findings consistent with an intracranial lesion. But biopsies in this region are not easy to obtain. Does an individual face mask help?

  • RET-He to diagnose iron-deficient erythropoiesis in dogsmembers
  • Hypertriglyceridemia-Associated Proteinuria in Miniature Schnauzersmembers
  • Gastrointestinal dysmotility disorders in critically ill animalsmembers
  • Disorder of sex development in a cat with chromosome mosaicism members
  • Generalized discoid lupus erythematosus in dogs members
  • Epidermolysis bullosa acquisita in dogsmembers
  • Chiari-Like Malformation and Syringomyelia in American Brussels Griffon Dogsmembers
  • Efficacy and Potential Complications of Transjugular Liver Biopsymembers
  • Hypomagnesemia in Brachycephalic Dogsmembers
  • Comparison of two minimally invasive techniques for liver biopsy members
  • Topical aqueous sirolimus and the tear production members
  • JAK 1/2 inhibitor in the treatment of canine B-cell lymphomamembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved